Page last updated: 2024-08-26

artesunic acid and Carcinoma, Epidermoid

artesunic acid has been researched along with Carcinoma, Epidermoid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Huang, X; Wang, W; Zhang, S1
Li, M; Meng, J; Sun, JH1
Hu, H; Ke, Y; Xiao, Q; Yang, L1
Chen, Y; Du, Y; Liu, J; Liu, L; Wang, J; Wang, L1
Efferth, T; Erich, SA; Fleckenstein, L; Grinwis, GC; London, CA; Mol, JA; Rutteman, GR; Spee, B1
Chai, J; Chen, W; Cheng, Y; Chuang, HH; Jiang, Z; Li, S; Wang, T; Zhou, D1

Other Studies

6 other study(ies) available for artesunic acid and Carcinoma, Epidermoid

ArticleYear
Artesunate restrains the malignant progression of human cutaneous squamous cell carcinoma cells via the suppression of the PI3K/AKT pathway.
    Tissue & cell, 2022, Volume: 76

    Topics: Apoptosis; Artesunate; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Insulin-Like Growth Factor I; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Skin Neoplasms

2022
[Artesunate inhibited human tongue squamous cell carcinoma CAL27 cells in vitro via STAT3 signaling pathway].
    Shanghai kou qiang yi xue = Shanghai journal of stomatology, 2022, Volume: 31, Issue:1

    Topics: Apoptosis; Artesunate; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Matrix Metalloproteinase 9; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; Tongue; Tongue Neoplasms; Vascular Endothelial Growth Factor A

2022
Artesunate targets oral tongue squamous cell carcinoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition.
    Journal of bioenergetics and biomembranes, 2020, Volume: 52, Issue:2

    Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Artesunate; Carcinoma, Squamous Cell; Humans; Mice; Mice, SCID; Mitochondria; Oxidative Stress; Proto-Oncogene Proteins c-akt; Tongue Neoplasms

2020
Correlation between adenosine triphosphate (ATP)-binding cassette transporter G2 (ABCG2) and drug resistance of esophageal cancer and reversal of drug resistance by artesunate.
    Pathology, research and practice, 2018, Volume: 214, Issue:9

    Topics: Adult; Aged; Animals; Antineoplastic Agents; Artemisinins; Artesunate; ATP Binding Cassette Transporter, Subfamily G, Member 2; Carcinoma, Squamous Cell; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Proteins; Xenograft Model Antitumor Assays

2018
Safety and efficacy field study of artesunate for dogs with non-resectable tumours.
    Anticancer research, 2013, Volume: 33, Issue:5

    Topics: Animals; Antimalarials; Artemisinins; Artesunate; Carcinoma, Squamous Cell; Cell Proliferation; Dog Diseases; Dogs; Lymphoma; Mouth Neoplasms; Treatment Outcome; Tumor Cells, Cultured

2013
Artesunate induces G0/G1 cell cycle arrest and iron-mediated mitochondrial apoptosis in A431 human epidermoid carcinoma cells.
    Anti-cancer drugs, 2012, Volume: 23, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Artemisinins; Artesunate; Carcinoma, Squamous Cell; Caspase 3; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; G1 Phase Cell Cycle Checkpoints; Humans; Iron; Keratinocytes; Mitochondria; Resting Phase, Cell Cycle

2012